Vanguard Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $446M | Sell |
1,846,543
-65,614
| -3% | -$15.8M | 0.01% | 1094 |
|
|
2025
Q1 | $466M | Sell |
1,912,157
-7,651
| -0.4% | -$1.86M | 0.01% | 1034 |
|
|
2024
Q4 | $631M | Buy |
1,919,808
+12,168
| +0.6% | +$4M | 0.01% | 902 |
|
|
2024
Q3 | $638M | Sell |
1,907,640
-466,867
| -20% | -$156M | 0.01% | 893 |
|
|
2024
Q2 | $649M | Sell |
2,374,507
-46,827
| -2% | -$12.8M | 0.01% | 831 |
|
|
2024
Q1 | $837M | Buy |
2,421,334
+31,445
| +1% | +$10.9M | 0.02% | 724 |
|
|
2023
Q4 | $772M | Buy |
2,389,889
+46,119
| +2% | +$14.9M | 0.02% | 733 |
|
|
2023
Q3 | $840M | Sell |
2,343,770
-51,443
| -2% | -$18.4M | 0.02% | 650 |
|
|
2023
Q2 | $908M | Sell |
2,395,213
-2,113
| -0.1% | -$801K | 0.02% | 648 |
|
|
2023
Q1 | $1.15B | Buy |
2,397,326
+5,890
| +0.2% | +$2.82M | 0.03% | 554 |
|
|
2022
Q4 | $1.01B | Buy |
2,391,436
+39,908
| +2% | +$16.8M | 0.03% | 579 |
|
|
2022
Q3 | $981M | Buy |
2,351,528
+2,428
| +0.1% | +$1.01M | 0.03% | 570 |
|
|
2022
Q2 | $1.16B | Buy |
2,349,100
+31,159
| +1% | +$15.4M | 0.03% | 525 |
|
|
2022
Q1 | $1.31B | Buy |
2,317,941
+30,476
| +1% | +$17.2M | 0.03% | 549 |
|
|
2021
Q4 | $1.73B | Buy |
2,287,465
+18,200
| +0.8% | +$13.8M | 0.04% | 479 |
|
|
2021
Q3 | $1.69B | Sell |
2,269,265
-12,433
| -0.5% | -$9.27M | 0.04% | 471 |
|
|
2021
Q2 | $1.47B | Sell |
2,281,698
-6,440
| -0.3% | -$4.15M | 0.04% | 515 |
|
|
2021
Q1 | $1.31B | Buy |
2,288,138
+15,765
| +0.7% | +$9M | 0.04% | 531 |
|
|
2020
Q4 | $1.32B | Buy |
2,272,373
+19,165
| +0.9% | +$11.2M | 0.04% | 491 |
|
|
2020
Q3 | $1.16B | Sell |
2,253,208
-52,973
| -2% | -$27.3M | 0.04% | 477 |
|
|
2020
Q2 | $1.04B | Buy |
2,306,181
+292,900
| +15% | +$132M | 0.04% | 484 |
|
|
2020
Q1 | $706M | Buy |
2,013,281
+35,754
| +2% | +$12.5M | 0.03% | 539 |
|
|
2019
Q4 | $732M | Buy |
1,977,527
+54,278
| +3% | +$20.1M | 0.03% | 662 |
|
|
2019
Q3 | $640M | Buy |
1,923,249
+19,938
| +1% | +$6.63M | 0.02% | 682 |
|
|
2019
Q2 | $595M | Sell |
1,903,311
-11,937
| -0.6% | -$3.73M | 0.02% | 724 |
|
|
2019
Q1 | $585M | Buy |
1,915,248
+29,183
| +2% | +$8.92M | 0.02% | 719 |
|
|
2018
Q4 | $438M | Buy |
1,886,065
+53,097
| +3% | +$12.3M | 0.02% | 765 |
|
|
2018
Q3 | $574M | Buy |
1,832,968
+35,261
| +2% | +$11M | 0.02% | 722 |
|
|
2018
Q2 | $519M | Buy |
1,797,707
+42,741
| +2% | +$12.3M | 0.02% | 755 |
|
|
2018
Q1 | $439M | Buy |
1,754,966
+31,854
| +2% | +$7.97M | 0.02% | 815 |
|
|
2017
Q4 | $411M | Buy |
1,723,112
+29,116
| +2% | +$6.95M | 0.02% | 845 |
|
|
2017
Q3 | $376M | Buy |
1,693,996
+14,591
| +0.9% | +$3.24M | 0.02% | 862 |
|
|
2017
Q2 | $380M | Buy |
1,679,405
+6,131
| +0.4% | +$1.39M | 0.02% | 831 |
|
|
2017
Q1 | $334M | Buy |
1,673,274
+58,774
| +4% | +$11.7M | 0.02% | 878 |
|
|
2016
Q4 | $294M | Buy |
1,614,500
+64,149
| +4% | +$11.7M | 0.02% | 925 |
|
|
2016
Q3 | $254M | Buy |
1,550,351
+52,157
| +3% | +$8.54M | 0.01% | 958 |
|
|
2016
Q2 | $214M | Buy |
1,498,194
+63,322
| +4% | +$9.06M | 0.01% | 1015 |
|
|
2016
Q1 | $196M | Buy |
1,434,872
+47,403
| +3% | +$6.48M | 0.01% | 1041 |
|
|
2015
Q4 | $192M | Buy |
1,387,469
+40,044
| +3% | +$5.55M | 0.01% | 1038 |
|
|
2015
Q3 | $181M | Buy |
1,347,425
+7,115
| +0.5% | +$956K | 0.01% | 1050 |
|
|
2015
Q2 | $202M | Buy |
1,340,310
+43,543
| +3% | +$6.56M | 0.01% | 1052 |
|
|
2015
Q1 | $175M | Buy |
1,296,767
+86,378
| +7% | +$11.7M | 0.01% | 1112 |
|
|
2014
Q4 | $146M | Buy |
1,210,389
+21,850
| +2% | +$2.63M | 0.01% | 1157 |
|
|
2014
Q3 | $135M | Buy |
1,188,539
+16,719
| +1% | +$1.9M | 0.01% | 1163 |
|
|
2014
Q2 | $140M | Buy |
1,171,820
+24,811
| +2% | +$2.97M | 0.01% | 1177 |
|
|
2014
Q1 | $147M | Buy |
1,147,009
+58,091
| +5% | +$7.44M | 0.01% | 1104 |
|
|
2013
Q4 | $135M | Buy |
1,088,918
+46,522
| +4% | +$5.75M | 0.01% | 1129 |
|
|
2013
Q3 | $123M | Buy |
1,042,396
+24,885
| +2% | +$2.93M | 0.01% | 1108 |
|
|
2013
Q2 | $114M | Buy |
+1,017,511
| New | +$114M | 0.01% | 1078 |
|